None listed
Conditions
Interventions
Intervention1: 2 billion counts of Bacillus coagulans OD for 14 days: Chewable tablet form
Control Intervention1: Placebo OD for 14 days: Chewable tablet form
Sponsors
Unique Biotech Ltd
SVS Institute of Dental Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Had not taken antibiotic or probiotic in any form within 2 weeks prior to the study. Who are willing to chew the tablet and participate in the study
Exclusion criteria
Exclusion criteria: - Children with acute infections, systemic diseases, immune-compromising conditions and special children. - Those who are not willing to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in levels of Mutans Streptococci, Lactobacilli and change in pH of saliva and plaqueTimepoint: 6 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| No change in levels of Mutans Streptococci, Lactobacilli and change in pH of saliva and plaqueTimepoint: 6 Months | — |
Countries
India
Contacts
Public ContactSurendra Reddy Munnangi
SVS Institute of dental sciences
Outcome results
None listed